<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02741180</url>
  </required_header>
  <id_info>
    <org_study_id>15-00116</org_study_id>
    <nct_id>NCT02741180</nct_id>
  </id_info>
  <brief_title>Sparsity-based Magnetic Resonance Imaging of Cardiac Arrhythmias</brief_title>
  <official_title>Sparsity-based Magnetic Resonance Imaging of Cardiac Arrhythmias</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NYU Langone Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NYU Langone Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary purpose of this study is to improve the quality of Magnetic Resonance Imaging in&#xD;
      patients with heart arrhythmia. Investigators will recruit 105 patients with arrhythmia and&#xD;
      30 control volunteers over 3 years and will use two arrhythmia-tolerant imaging methods for&#xD;
      diagnosis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the proposed research, investigators will extend conventional cardiac magnetic resonance&#xD;
      methods to enable the creation of high-quality cine CMR images in the presence of multiple&#xD;
      kinds of arrhythmia. Two arrhythmia-tolerant imaging methods will be adopted, which are&#xD;
      particularly useful in arrhythmia: 1) 3D imaging, which is useful for many purposes,&#xD;
      including &quot;road mapping&quot; of electrophysiology (EP) procedures, and 2) late gadolinium&#xD;
      enhancement (LGE), which is useful for delineating abnormal myocardium, including fibrotic&#xD;
      regions that can serve as sources of arrhythmias.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    COVID-19&#xD;
  </why_stopped>
  <start_date type="Actual">September 29, 2017</start_date>
  <completion_date type="Anticipated">August 2022</completion_date>
  <primary_completion_date type="Anticipated">August 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Paired-sample Wilcoxon signed rank test to evaluate measures on Likert scales</measure>
    <time_frame>3 Years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Paired-sample t tests for quantitative measures of intensity of image artifacts</measure>
    <time_frame>3 Years</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">135</enrollment>
  <condition>Cardiac Arrythmias</condition>
  <arm_group>
    <arm_group_label>Patients with Arrhythmias</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>3D Imaging</intervention_name>
    <description>&quot;roadmapping&quot; of electrophysiology (EP) procedures</description>
    <arm_group_label>Healthy Control</arm_group_label>
    <arm_group_label>Patients with Arrhythmias</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Late Gadolinium Enhancement (LGE)</intervention_name>
    <description>useful for delineating abnormal myocardium, including fibrotic regions that can serve as sources of arrhythmias.</description>
    <arm_group_label>Healthy Control</arm_group_label>
    <arm_group_label>Patients with Arrhythmias</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria for Arrhythmia Patients:&#xD;
&#xD;
          -  Patients diagnosed with heart arrhythmia scheduled for routine clinical MRI&#xD;
             examinations).&#xD;
&#xD;
          -  Patients scheduled for routine clinical MRI examinations who do not have a specific&#xD;
             known diagnosis of arrhythmia, but who may be found to have image degradation due to&#xD;
             arrhythmia during the CMR examination.&#xD;
&#xD;
        Inclusion Criteria for Controls:&#xD;
&#xD;
          -  No history of heart arrhythmia.&#xD;
&#xD;
        Exclusion Criteria for Patients and Controls:&#xD;
&#xD;
          -  Hemodynamic instability.&#xD;
&#xD;
          -  Contraindications for MRI examinations (e.g., pacemakers or ferromagnetic vascular&#xD;
             clips).&#xD;
&#xD;
          -  History of prior cardiovascular disease or significant risk factors:&#xD;
&#xD;
               -  Diabetes, hypertension, smoking, and hyperlipidemia, etc.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leon Axel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York University Medical School</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>New York University School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>March 29, 2016</study_first_submitted>
  <study_first_submitted_qc>April 13, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 18, 2016</study_first_posted>
  <last_update_submitted>August 23, 2021</last_update_submitted>
  <last_update_submitted_qc>August 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

